Kenneth DiPietro

Filings by Kenneth DiPietro span 2 companies, the busiest being Biogen Inc. and Cerevel Therapeutics Holdings, Inc. Between 1 February 2013 and 1 August 2024, the trades on record add up to 40 filings.

On the market, this insider has only sold: 8 sales, €2.8M in total. Outside the open market, there are 14 share grants and 17 option exercises.

The record was last updated on 5 August 2024 with a transaction in Cerevel Therapeutics Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.